We are live on ! Find out more
CCA

Conestoga Capital Advisors Portfolio holdings

AUM $4.6B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
-5.54%
1 Year Est. Return
+16.08%
3 Year Est. Return
+47.77%
5 Year Est. Return
+64.2%
10 Year Est. Return
+537.64%
AUM
$1.58B
AUM Growth
+$92.6M
Cap. Flow
+$199M
Cap. Flow %
12.58%
Top 10 Hldgs %
29.03%
Holding
140
New
2
Increased
50
Reduced
52
Closed
5

Sector Composition

Rank Sector Weight
1 Technology 24.23%
2 Healthcare 16.21%
3 Industrials 15.07%
4 Materials 8.3%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLKB icon
26
Blackbaud
BLKB
$2.08B
$32.7M 2.07%
1,043,734
+155,064
+17% +$5.22M
EGOV
27
DELISTED
NIC Inc
EGOV
$32.7M 2.07%
1,691,403
+621,512
+58% +$12.9M
MCF
28
DELISTED
Contango Oil & Gas Co.
MCF
$31.7M 2.01%
664,730
+100,834
+18% +$4.62M
MTDR icon
29
Matador Resources
MTDR
$5.84B
$31.5M 1.99%
1,286,423
+197,389
+18% +$4.25M
PRLB icon
30
Protolabs
PRLB
$2.16B
$30.9M 1.95%
456,317
+66,525
+17% +$4.95M
FLTX
31
DELISTED
Fleetmatics Group PLC
FLTX
$30M 1.9%
896,550
+144,635
+19% +$5.47M
ADVS
32
DELISTED
Advent Software Inc
ADVS
$29.9M 1.89%
1,019,870
+160,385
+19% +$5.11M
HIBB
33
DELISTED
Hibbett, Inc. Common Stock
HIBB
$28M 1.77%
529,196
+60,742
+13% +$3.58M
ROL icon
34
Rollins
ROL
$18.1B
$26.7M 1.69%
2,979,413
+168,429
+6% +$1.47M
SSYS icon
35
Stratasys
SSYS
$778M
$26.5M 1.68%
250,011
+16,946
+7% +$2.03M
HITT
36
DELISTED
HITTITE MICROWAVE CORP
HITT
$26.4M 1.67%
418,027
+56,767
+16% +$3.38M
MDSO
37
DELISTED
Medidata Solutions, Inc.
MDSO
$25.9M 1.64%
477,017
+31,090
+7% +$1.89M
MLAB icon
38
Mesa Laboratories
MLAB
$574M
$23M 1.45%
254,311
+105,455
+71% +$8.96M
MORN icon
39
Morningstar
MORN
$7.48B
$18.4M 1.16%
232,716
+12,658
+6% +$1.01M
NRC icon
40
NRC Health Common Stock
NRC
$433M
$16.1M 1.02%
971,418
+74,227
+8% +$1.24M
VIVO
41
DELISTED
Meridian Bioscience Inc
VIVO
$15.9M 1.01%
730,597
-260,915
-26% -$5.98M
NVEC icon
42
NVE Corp
NVEC
$613M
$15.4M 0.98%
270,632
+36,962
+16% +$2.12M
CMD
43
DELISTED
Cantel Medical Corporation
CMD
$15M 0.95%
+444,000
New +$14.6M
TECH icon
44
Bio-Techne
TECH
$11.2B
$14.9M 0.94%
699,916
+44,564
+7% +$1M
NRCIB
45
DELISTED
National Research Corp Class B
NRCIB
$14.4M 0.91%
328,178
+105,324
+47% +$4.06M
MED icon
46
Medifast
MED
$137M
$13.9M 0.88%
478,063
+114,893
+32% +$3.08M
ACTG icon
47
Acacia Research
ACTG
$439M
$11.5M 0.73%
755,732
+104,227
+16% +$1.52M
EXA
48
DELISTED
EXA Corporation
EXA
$7.76M 0.49%
585,500
+101,461
+21% +$1.44M
XOM icon
49
ExxonMobil
XOM
$628B
$4.08M 0.26%
41,778
-1,400
-3% -$133K
UFI icon
50
UNIFI
UFI
$123M
$3.48M 0.22%
150,779
+1,500
+1% +$36.6K

Similar funds

Conestoga Capital Advisors's Q1 2014 Portfolio in Review

As of Q1 2014, Conestoga Capital Advisors held 140 positions worth $1.58B, up 6.2% from $1.49B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Conestoga Capital Advisors deployed $199M of net new capital in Q1 2014, opening 2 new positions and adding to 50 existing holdings. Its largest new stake was Cantel Medical Corporation: 444,000 shares worth $15M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was CoStar Group, an estimated $16.9M trimmed.

  • Conestoga Capital Advisors's largest Q1 2014 buy was Cantel Medical Corporation: 444,000 shares worth $15M.
  • Conestoga Capital Advisors added most to Dorman Products in Q1 2014, an estimated $21.5M increase.
  • Conestoga Capital Advisors's biggest Q1 2014 reduction was CoStar Group, cutting an estimated $16.9M.
  • Conestoga Capital Advisors fully exited Accelrys Inc in Q1 2014, selling an estimated $20.3M.
  • Conestoga Capital Advisors's ten largest holdings make up 29% of its $1.58B portfolio in Q1 2014.
  • Conestoga Capital Advisors opened 2 new positions and closed 5 in Q1 2014.
  • Conestoga Capital Advisors's portfolio value rose 6.2% quarter-over-quarter to $1.58B.

Based on Conestoga Capital Advisors's 13F filing for Q1 2014, filed 23 Apr 2014.